Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

TELA Bio (TELA) Other Non Operating Income (2018 - 2026)

TELA Bio has reported Other Non Operating Income over the past 8 years, most recently at -$1.9 million for Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 765.96% year-over-year to -$1.9 million; the TTM value through Dec 2025 reached -$888000.0, down 162.54%, while the annual FY2025 figure was -$888000.0, 162.54% down from the prior year.
  • Other Non Operating Income for Q4 2025 was -$1.9 million at TELA Bio, down from $152000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $870000.0 in Q2 2023 and troughed at -$1.9 million in Q4 2025.
  • A 5-year average of $74105.3 and a median of $285000.0 in 2024 define the central range for Other Non Operating Income.
  • Biggest five-year swings in Other Non Operating Income: plummeted 1435.0% in 2022 and later skyrocketed 542.06% in 2023.
  • Year by year, Other Non Operating Income stood at -$43000.0 in 2021, then crashed by 353.49% to -$195000.0 in 2022, then surged by 475.9% to $733000.0 in 2023, then crashed by 61.12% to $285000.0 in 2024, then tumbled by 765.96% to -$1.9 million in 2025.
  • Business Quant data shows Other Non Operating Income for TELA at -$1.9 million in Q4 2025, $152000.0 in Q3 2025, and $379000.0 in Q2 2025.